# Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

> **NCT07727694** · — · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 1600 (estimated)

## Conditions studied

- Pediatric Cancer

## Interventions

- **OTHER:** data collection

## Key facts

- **NCT ID:** NCT07727694
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727694, "Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*